"A world-wide prospective study of INC on prognosis and biomarkers in GBS"

A world-wide prospective study of INC on prognosis and biomarkers in GBS

PNS virtual meeting 2020

During the first virtual PNS Annual Meeting, the IGOS Meeting was also held online for the first time. We celebrate a succesful meeting but hope the next PNS meeting will be held in person in the beautiful Copenhagen.More >>

COVID-19 and GBS

As a first step to investigate the possible relationship between COVID-19 and GBS, we have lauched a substudy within IGOS. More >>
More news

International Guillain-Barré syndrome outcome study (IGOS)



Welcome to the website for the International Guillain-Barré syndrome Outcome Study (IGOS). The study aims to identify clinical and biological determinants and predictors of disease course in Guillain-Barré syndrome. The study is conducted by the Inflammatory Neuropathy Consortium (INC). At this website you can acquire information about IGOS, register as IGOS participant and include patients with Guillain-Barré syndrome. For more information about IGOS, click here.